Unusual presentation of COVID-19 in a child complicated by massive acute pulmonary embolism and lung infarction
The Novel Coronavirus 2019 (SARSCoV- 2), which was first reported on in Wuhan, China, in late December 2019, causes a respiratory illness called COVID- 19 Disease. COVID-19 is most likely causing a hypercoagulable state, however the prevalence of acute venothromboembolism is still unknown. Limited data suggest pulmonary microvascular thrombosis may play a role in progressive respiratory failure. Here, we report a case of a child with an unusual presentation of COVID-19 presented initially by dry cough without fever and complicated by massive acute pulmonary embolism and lung infarction and treated successfully by hydroxychloroquine and azithromycin, in addition to anticoagulant therapy.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506. DOI: https://doi.org/10.1016/S0140-6736(20)30183-5
Tan W, Zhao X, Ma X, et al. Notes from the field: a novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019-2020. China CDC Weekly. 2020;2(4):61-62. DOI: https://doi.org/10.46234/ccdcw2020.017
Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020;25(3):278–280. DOI: https://doi.org/10.1111/tmi.13383
Centers for Disease Control and Prevention, “What healthcare personnel should know about caring for patients with confirmed or possible coronavirus disease 2019 (COVID-19),” vol. 2019, p. 315495, 2020.
Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382:1708-1720.
Zhou F, Yu T, Du R, et al. Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet 2020; 395 (10229) P1054-1062. DOI: https://doi.org/10.1016/S0140-6736(20)30566-3
Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19) . (2020).Accessed: March 21, 2020: https://www.who.int/docs/default-source/coronaviruse/whochina-joint-mission-on-covid-19.
Guan W-j, Ni Z-y, Hu Y, et al.: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382:1708-1720. DOI: https://doi.org/10.1056/NEJMoa2002032
Wei M, Yuan J, Liu Y, et al.: Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA. 2020;323(13):1313-1314. DOI: https://doi.org/10.1001/jama.2020.2131
Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334-346. DOI: https://doi.org/10.1056/NEJMoa2021680
Ai T, Yang Z, Hou H, et al.: Correlation of chest CT and RT-PCR testing in Coronavirus Disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020; Aug;296(2):E32-E40. DOI: https://doi.org/10.1148/radiol.2020200642
Uthman IW, Gharavi AE. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum 2002;31(4):256-63. DOI: https://doi.org/10.1053/sarh.2002.28303
Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med 2020; 382:e38. DOI: https://doi.org/10.1056/NEJMc2007575
- Abstract views: 198
- PDF: 112
- HTML: 0
Copyright (c) 2021 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.